Physician profile
Aarti Patel
NPI 1003174939
$3,774.29
in general payments reported to CMS, 2019-2025
14 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2021: $646 · 2022: $726 · 2023: $1,067 · 2024: $716 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,173.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $1,057.73 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Axsome Therapeutics, INC. | $977.48 | 2023-2025 | Auvelity, Sunosi |
| Corium, LLC | $490.07 | 2021-2023 | Azstarys |
| Abbvie INC. | $348.17 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $171.64 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $144.01 | 2019-2021 | |
| Neos Therapeutics, LP | $141.44 | 2022-2023 | Cotempla Xr-Odt |
| Otsuka America Pharmaceutical, INC. | $134.26 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $68.51 | 2023 | |
| Alkermes, INC. | $57.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.71 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.25 | 2019 | |
| Allergan, INC. | $17.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aarti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.